Radio segment includes views of NFCA's Alice Bast on impact of new products.
04/02/2007Alvine Pharmaceuticals, Inc., a biopharmaceutical company focused on developing pharmaceutical products for the treatment of celiac sprue, announced the closing of a $21 million Series A financing.
10/18/2006Early testssuggest therapy with combination of enzymes inactivates gluten in the gut and may benefit patients with celiac disease.
06/28/2006Philadelphia Area doctors teamed with Drexel University Culinary Arts students to create gluten-free delights!
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to